These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35518821)

  • 1. Facial diplegia with paresthesia associated with anti-GD1a antibodies.
    Strawbridge J; Fu KA; Chan J; Flavin W; Cohen J; Keselman I; Shieh P
    Proc (Bayl Univ Med Cent); 2022; 35(3):387-388. PubMed ID: 35518821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Guillain-Barré syndrome variant with prominent facial diplegia.
    Susuki K; Koga M; Hirata K; Isogai E; Yuki N
    J Neurol; 2009 Nov; 256(11):1899-905. PubMed ID: 19633904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome variant with facial diplegia and paresthesias associated with IgM anti-GalNAc-GD1a antibodies.
    Hayashi R; Yamaguchi S
    Intern Med; 2015; 54(3):345-7. PubMed ID: 25748745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ataxic Guillain-Barré syndrome with delayed facial diplegia].
    Atsumi M; Kitaguchi M; Chimoto Y; Nishikawa S; Mineta H; Nakasaka Y; Tanaka H; Susuki K
    Rinsho Shinkeigaku; 2003 Sep; 43(9):548-51. PubMed ID: 14727561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.
    Castiglione JI; Crespo JM; Lecchini L; Silveira FO; Luis MB; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Barroso F
    Neuromuscul Disord; 2022 Jul; 32(7):572-574. PubMed ID: 35644722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A variant of Guillain-Barré syndrome with prominent bilateral peripheral facial nerve palsy--facial diplegia and paresthesias].
    Atsumi M; Kitaguchi M; Nishikawa S; Susuki K
    Rinsho Shinkeigaku; 2004 Aug; 44(8):549-52. PubMed ID: 15471093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré Syndrome: A Variant Consisting of Facial Diplegia and Paresthesia with Left Facial Hemiplegia Associated with Antibodies to Galactocerebroside and Phosphatidic Acid.
    Nishiguchi S; Branch J; Tsuchiya T; Ito R; Kawada J
    Am J Case Rep; 2017 Oct; 18():1048-1052. PubMed ID: 28966341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias.
    Wakerley BR; Yuki N
    Muscle Nerve; 2015 Dec; 52(6):927-32. PubMed ID: 26315943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifacial weakness with paresthesias: Serial nerve conduction studies indicate diffuse demyelinating neuropathy.
    Morgan C; Fuller G; Wakerley BR
    Muscle Nerve; 2016 May; 53(5):818-22. PubMed ID: 26790030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report.
    Zubair AS; Bae JY; Desai K
    Cureus; 2022 Feb; 14(2):e22341. PubMed ID: 35371813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facial Diplegia with Paresthesia: An Uncommon Variant of Guillain-Barre Syndrome.
    Kumar P; Charaniya R; Bahl A; Ghosh A; Dixit J
    J Clin Diagn Res; 2016 Jul; 10(7):OD01-2. PubMed ID: 27630886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When is facial diplegia regarded as a variant of Guillain-Barré syndrome?
    Kim JK; Oh SY; Sohn EH; Hong YH; Jun SM; Bae JS
    J Peripher Nerv Syst; 2015 Mar; 20(1):32-6. PubMed ID: 25975218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
    Chatani H; Tanaka M; Nagata T; Araki T; Kusunoki S
    J Clin Neurosci; 2014 Jan; 21(1):170-2. PubMed ID: 23916762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral Facial Palsy and Hyperreflexia as the Main Clinical Presentation in Guillain-Barré Syndrome.
    Albuainain G
    Am J Case Rep; 2021 Oct; 22():e932757. PubMed ID: 34597290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody].
    Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K
    Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study.
    Kim JK; Bae JS; Kim DS; Kusunoki S; Kim JE; Kim JS; Park YE; Park KJ; Song HS; Kim SY; Lim JG; Kim NH; Suh BC; Nam TS; Park MS; Choi YC; Sohn EH; Na SJ; Huh SY; Kwon O; Lee SY; Lee SH; Oh SY; Jeong SH; Lee TK; Kim DU
    J Clin Neurol; 2014 Apr; 10(2):94-100. PubMed ID: 24829594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Facial diplegia with atypical paresthesia. A variant of Guillain-Barré syndrome].
    Dal Verme A; Acosta P; Margan M; Pagnini C; Dellepiane E; Peralta C
    Medicina (B Aires); 2015; 75(3):178-80. PubMed ID: 26117611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.